Medify Solutions Ltd (Pink Sheets: MFYS) Extraordinary Dividend Eligibility Closes on Friday 28th July, 2006

Toronto (ots/PRNewswire) - The board of Medify Solutions Limited
has announced the confirmation of the extraordinary share dividend
following its European subsidiary float. As stated, all shareholders
in Medify Solutions Limited (Pink Sheets: MFYS) will receive a share
for share dividend granted on floatation. For every share held in
Medify Solutions Limited, existing share holders will receive a
reciprocal free trading share in the European operation. Eligibility
for this dividend is valid for all shareholders and closes at the
close of the market on Friday 28th July 2006. Jonathan Bryant,
Executive Chairman, said: "The announcement of the closing date for
eligibility for the shareholders' extraordinary dividend is a clear
mark of intent and a demonstration of the progress of the company. I
hope all Medify shareholders will take confidence in this
announcement and look forward to the future and the success of
Medify, now on a global basis." He added: "I congratulate the team
for making this a reality and we as shareholders should be extremely
excited about this confirmation. The plans, the vision and the
success are now becoming the reality for the Medify Group of
companies. I believe these will prove to be exciting and profitable
times for anyone associated with Medify especially those who have a
shareholding." Every share held by a shareholder at the closing of
the market on Friday July 28th 2006 will be entitled to the
extraordinary dividend.

Medify Solutions Inc. (Pink Sheets: MFYS) is the first business to
have developed a Secure Remote Access product, addressing critical
requirements of the UK National Health Service, and many other
medical computer systems, bringing the latest flexible integrated
wireless and web-based technologies for healthcare revision.
MedifyRemote, its leading product, is an application that allows
remote access to a patient's record through a Pocket PC. This
solution is not specific to any single clinical data system, but
applicable to all the NHS /Healthcare software systems in any
healthcare market. The company's website is
http://www.medifysolutions.com.

This news release contains forward-looking statements that are
subject to certain risks and uncertainties that may cause actual
results to differ materially from those projected on the basis of
such forward-looking statements. The words "estimate," "project,"
"intends," "expects," "believes," and similar expressions are
intended to identify forward-looking statements. Such forward-looking
statements are made based on management's beliefs, as well as
assumptions made by, and information currently available to,
management pursuant to the "safe-harbour" provisions of the Private
Securities Litigation Reform Act of 1995. For a more complete
description of these and other risk factors that may affect the
future performance of Medify Solutions Limited, see "Risk Factors" in
the Company's Annual Report on Form 10-KSB and its other filings with
the Securities and Exchange Commission. Readers are cautioned not to
place undue reliance on these forward-looking statements, which speak
only as of the date made and the Company undertakes no obligation to
disclose any revision to these forward-looking statements to reflect
events or circumstances after the date made or to reflect the
occurrence of unanticipated events.

ots Originaltext: Medify Solutions
Im Internet recherchierbar: http://www.presseportal.de

Contact:
Medify Press Office: press@medifysolutions.com. Jonathan Bryant,
Group Chairman, +44-(0)845-034-4090